MICHAEL LIEBOWITZ: Open Payments
NPI 1821150129 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 6 payments from 5 companies in 2025. Trend: 2023 $95 · 2024 $175 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $49 |
| ABBVIE INC. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: VRAYLAR, UZEDY, ARISTADA, ABILIFY MAINTENA, VIVITROL, INGREZZA.
Industry payments across MA — which companies pay providers there.
